Catalyst Wire Dossier Catalyst Wire Dossier

Physiologic Insulin Resensitization

Physiologic Insulin Resensitization
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Physiologic Insulin Resensitization, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus [NA]

See pricing